Skip to main content
Retour
Watch Compare

Kraig Biocraft Laboratories, Inc.

Qualité des données : 83%
KBLB
OTC Manufacturing Chemicals
0,14 €
▲ 0,01 € (6,15%)
Cap. Boursière: 151,77 M
Prix
0,14 €
Cap. Boursière
151,77 M
Fourchette du Jour
0,13 € — 0,14 €
Fourchette 52 Semaines
0,07 € — 0,15 €
Volume
616 710
Ouverture 0,13 €
Moyenne 50J / 200J
0,11 €
26,61% above
Moyenne 50J / 200J
0,09 €
51,65% above

Quick Summary

Points Clés

Negative free cash flow of -1,79 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,16
Interest Coverage-5,91

Valorisation

PE (TTM)
-41,89
En dessous de la moyenne du secteur (-1,98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (44 pairs)
Métrique Action Médiane du Secteur
P/E -41,9 -2,0
P/B — 5,1
ROE % — -51,0
Net Margin % — -150,2
Rev Growth 5Y % — 9,3
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -3,62 M
ROE N/A ROA -183,56%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -1,79 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,16
Interest Coverage -5,91 Asset Turnover N/A
Working Capital -8,54 M Tangible Book Value -7,96 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -41,89 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -1,18%
Market Cap 151,77 M Enterprise Value 150,21 M
Per Share
EPS (Diluted TTM) 0,00 Revenue / Share N/A
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 49,52%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -3,62 M -3,40 M -3,03 M -3,84 M -8,05 M
EPS (Diluted) 0,00 0,00 0,00 — —
Gross Profit — — — — —
Operating Income -3,37 M -3,07 M -2,61 M -2,12 M -2,76 M
EBITDA — — — — —
R&D Expenses 165 758,0 164 374,0 237 871,0 176 431,0 197 745,0
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 570 709,0 529 603,0 153 955,0 153 955,0 238 110,0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2,57 M 1,51 M 3,23 M 4,57 M 3,02 M
Total Liabilities 10,56 M 9,65 M 8,94 M 8,09 M 8,32 M
Shareholders' Equity -8,00 M -8,15 M -5,71 M -3,52 M -5,30 M
Total Debt — — — — —
Cash & Equivalents 1,79 M 673 264,0 2,55 M — —
Current Assets 1,87 M 740 285,0 2,57 M 3,98 M 2,37 M
Current Liabilities 10,45 M 9,61 M 8,89 M 8,07 M 8,16 M